All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 9 out of 9 Insights
As AI continues to evolve, we may see a shift in how organizations across industries derive insights from unstructured data, adding a powerful tool in decision-making processes.
Health care continued to evolve in transformational ways during 2023. As we look ahead, we reflect on the topics explored through our Corporate Learning Insights in 2023.
When teaching complex biomedical concepts, a strong course curriculum is important, but the visual aspects of the course are just as important to help learners understand the material more deeply.
We sat down with Guido Scholze, the global head of UME at Boehringer Ingelheim, to discuss the programs’ successes and how they fit into Boehringer Ingelheim’s strategic goals.
Being diagnosed with and then recovering from lymphoma changed my life for the better. I’ve witnessed remarkable academic and industry collaboration, including the cooperation that saved my life.
The COVID-19 pandemic has led to three key trends in the biopharmaceutical industry: new therapeutic modalities, increased data usage, and stronger collaboration between industry and academia.
Online courses provide a convenient and flexible option, but can they truly deliver significant knowledge gains? Researchers from Harvard Medical School conducted a study to answer this question.
Students will advance their knowledge and professional potential in meaningful areas of health care like clinical and translational research.
Cross-functional communication is vital to any successful business.